Drug Type CRISPR/Cas9 |
Synonyms- |
Target |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | - | 31 Aug 2023 | |
Congenital Disorders | Discovery | - | 31 Aug 2023 | |
Digestive System Disorders | Discovery | - | 31 Aug 2023 | |
Hematologic Diseases | Discovery | - | 31 Aug 2023 | |
Neoplasms | Discovery | - | 31 Aug 2023 | |
Nervous System Diseases | Discovery | - | 31 Aug 2023 | |
Nutritional and Metabolic Diseases | Discovery | - | 31 Aug 2023 | |
Rare Diseases | Discovery | - | 31 Aug 2023 | |
Schizophrenia | Discovery | - | 31 Aug 2023 | |
Urogenital Diseases | Discovery | - | 31 Aug 2023 |